RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in ...

RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in ...

Palo Alto, April 17, 2025 (GLOBE NEWSWIRE) -- Cancer patients don’t just fight the disease - they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to manual, error-prone workflows. To solve this, RISA…

Risa Labs Raises $3.5M in Seed Funding

Risa Labs, a Palo Alto, CA-based oncology AI company, raised $3.5M in funding. The round was led by Binny Bansal (Flipkart co-founder) with participation from Oncology Ventures, General Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta. The company intends to use the capital to accelerate deployments in the next 100 cancer centers across the […] The post Risa Labs Raises $3.5M in Seed Funding appeared first on FinSMEs.

RISA Labs Raises $3.5M to Accelerate Cancer Treatment with AI Operating System

In a healthcare system where cancer patients often wait days—or even weeks—for life-saving treatments due to administrative red tape, RISA Labs is stepping in with a powerful, AI-native solution designed to eliminate one of the most persistent bottlenecks in oncology: prior authorization delays. Today, the Palo Alto-based startup announced a $3.5 million seed round led by Binny Bansal, co-founder of Flipkart, with support from Oncology Ventures,…

RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in Oncology

Palo Alto, April 17, 2025 (GLOBE NEWSWIRE) — Cancer patients don’t just fight the disease – they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to manual, error-prone workflows. To solve this, RISA Labs has raised a $3.5M funding round to help healthcare organizations eliminate one of the […]

RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in Oncology - Digital Health Technology News

Cancer patients don’t just fight the disease – they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to manual, error-prone workflows. To solve this, RISA Labs has raised a $3.5M funding round to help healthcare organizations eliminate one of the most persistent barriers to timely cancer care: prior authorization delays. RISA Labs has already proven that faster care is possible by dramatically reduc…

RISA Labs raises USD $3.5m to automate cancer workflows

RISA Labs has raised USD $3.5 million to advance its AI-driven platform, aiming to cut delays in cancer care by automating prior authorisations across 100 centres.